Patients are expected to acquire peptide products through unconventional channels, such as telephone numbers or online platforms. These products are characterized as being less expensive and lacking proper validation. This method of acquisition will allow individuals to circumvent the traditional process of consulting with medical doctors.
Opting for these direct purchase routes means patients will miss essential appointments with genuine medical professionals. These doctors are crucial for providing precise health evaluations and ensuring access to treatments that have been thoroughly established as effective. As a direct result, patients choosing these unproven peptide products face a significant risk of encountering fraudulent schemes and missing out on necessary, verifiable medical care.